glp-1 receptor agonists weight loss effectiveness Study finds target fat over muscle for Reported weight-loss outcomes associated with
Description
Its active ingredient, tirzepatide, is a synthetic polypeptide that mimics the actions of these hormones
The GLP-1 receptor activation in both drugs improves insulin secretion and glycemic control
Cardiovascular and kidney outcomes and mortality with long-acting injectable and oral glucagon-like peptide 1 receptor agonists in individuals with type 2 diabetes: A systematic review and meta-analysis of randomized trials
For all-cause mortality, the five-year survival probability was 96.9% with GLP-1RAs and 82.3% with insulin/metformin
Now, a weekly injection could deliver similar results without surgery
